Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Mitoxantrone repression of astrocyte activation: Relevance to multiple sclerosis.
The INCAT disability score: A critical analysis of its measurement properties.
Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis.
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab.
Correction: Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: the EVIDENCE Study.
Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
Chemical and Biological Therapeutic Approaches to Neurological Disorders III
Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro.
FDA Drug Safety Communication: FDA warns about case of rare brain infection PML with MS drug Tecfidera (dimethyl fumarate)
How many injections did you miss last month? A simple question to predict interferon β-1a adherence in multiple sclerosis.
Dimethyl fumarate (BG-12, Tecfidera) - NICE gives initial "no" decision
Neuronal expression of pathological tau accelerates oligodendrocyte progenitor cell differentiation.
Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROS.
American Society for Neurochemistry Annual Meeting
Glatiramer Acetate Guards Against Rapid Memory Decline During Relapsing-Remitting Experimental Autoimmune Encephalomyelitis.
Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results.
Regulation of prefrontal cortex myelination by the microbiota.
Drugs@FDA (Enter "glatiramer acetate" in search box.)
Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials.
Dimethyl fumarate inhibits integrin α4 expression in multiple sclerosis models.
Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.
Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide.
Glatiramer Acetate and Nanny Proteins Restrict Access of the Multiple Sclerosis Autoantigen Myelin Basic Protein to the 26S Proteasome.

Pages